V gamma 9V delta 2 T cell response to colon carcinoma cells.
about
What lessons can be learned from γδ T cell-based cancer immunotherapy trials?Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney TransplantationImmunotherapy for colorectal cancerSelf/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells.NK cells and gammadelta T cells mediate resistance to polyomavirus-induced tumors.Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection.Aminobisphosphonate-pretreated dendritic cells trigger successful Vgamma9Vdelta2 T cell amplification for immunotherapy in advanced cancer patients.The feature of distribution and clonality of TCR γ/δ subfamilies T cells in patients with B-cell non-Hodgkin lymphoma.Signal transduction by different forms of the γδ T cell-specific pattern recognition receptor WC1.Gammadelta T cell immune manipulation during chronic phase of simian-human immunodeficiency virus infection [corrected] confers immunological benefits.Prolonged (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-driven antimicrobial and cytotoxic responses of pulmonary and systemic Vgamma2Vdelta2 T cells in macaquesComparison of T-cell receptor repertoire restriction in blood and tumor tissue of colorectal cancer patients.Murine CD27(-) Vγ6(+) γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophagesIndividual Vgamma2-Jgamma1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens.Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by Vγ9Vδ2 T cells.γδ T cells cross-link innate and adaptive immunity in Mycobacterium tuberculosis infection.Immune therapy for breast cancer in 2010-hype or hope?γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody.Plasticity of γδ T Cells: Impact on the Anti-Tumor ResponseChemotherapy sensitizes colon cancer initiating cells to Vγ9Vδ2 T cell-mediated cytotoxicityA gene expression signature from peripheral whole blood for stage I lung adenocarcinoma.γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytesHuman gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.Attenuated mutant strain of Salmonella Typhimurium lacking the ZnuABC transporter contrasts tumor growth promoting anti-cancer immune response.Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronateImpacts of HIV infection on Vgamma2Vdelta2 T cell phenotype and function: a mechanism for reduced tumor immunity in AIDSHuman gamma delta T cells: candidates for the development of immunotherapeutic strategies.Leukocyte populations and IL-6 in the tumor microenvironment of an orthotopic colorectal cancer modelIsopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR.New frontiers in cell-based immunotherapy of cancer.γδ T cells and their potential for immunotherapy.Colorectal cancer and immunity: what we know and perspectives.Tumor-activated TCRγδ⁺ T cells from gastric cancer patients induce the antitumor immune response of TCRαβ⁺ T cells via their antigen-presenting cell-like effects.CDR3δ -grafted γ9δ2T cells mediate effective antitumor reactivity.Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells.Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette-Guérin.Immunotherapy targeting colon cancer stem cells.
P2860
Q26849323-BD49E80B-BB8C-4E3E-BE86-9BDC81706E05Q26863724-913AD763-33F4-450E-A301-5A94C85CD29DQ27021837-1E781228-E8B8-4FF3-A5EC-853536A976B6Q28287583-1C707A2D-BE43-4EE2-9324-CEFD4F721AC9Q33436859-8A05B350-074E-46B3-A0C4-AE95291F9978Q33455830-85AB5D01-5B75-4AA1-9F8F-48679BE7A149Q33594446-78200D4B-51F4-451E-99EA-52EB43D9765BQ33612830-563318AB-F65D-4BDF-AF30-5BA51D465229Q33617841-93D6F8EE-34D6-4142-8ED3-465E4D0212CDQ33747619-50073438-93B5-415B-A516-2E71461A2A4CQ33795825-F586EB2B-9905-41D5-A0B5-253343359894Q33825327-FC7E5B9C-52E5-4D2F-9AFF-E5CA62E20628Q33832188-F1CB1FFC-53EE-4B52-943B-96D5DC2A458BQ33863905-B6E44789-6365-4ABF-9FE4-77652249C1C2Q34119854-6F71E22E-6022-4613-9D97-2F0284E363BBQ34170227-6CC7CC2A-7F9B-42F9-B6FE-337B6A8A7C3EQ34395222-9AAC07C7-F9A4-44AB-A881-EDD0FB1530F1Q34496948-664DCF58-6A81-46C7-B979-25481ADEA10CQ34541467-73871BFB-D7BE-46E7-8311-EAB50AB14AC9Q34612619-BF418B18-E803-4111-A063-0012537CFB25Q34652408-7EEC24B4-20AA-42F2-9688-77A7CFD336CAQ34769652-FAB0938F-A29B-4AD5-ADB3-11632DF51A5CQ35281526-16A37C46-EE8C-4248-AFB5-3FD3A191B135Q35634919-97699F7D-03C0-49B5-B776-E40FDD584086Q35883004-D26717B7-00BE-4FA8-A3A8-E27BD089BF5EQ36232119-4D3F868A-0BDA-407C-804F-1F81EF347C28Q36734208-28109484-0FCF-4E30-92C8-17F670A81B9BQ36803857-8C193796-AB51-4079-8D58-8C26DBF268F0Q36908780-AD6E4441-01C7-484E-B68B-4DF49ED1E230Q36949584-0B1EC405-A7B6-4A61-A22B-80E0737FDADCQ37038276-5E98FC8A-38BC-47A2-976D-B7750E34AFCEQ37344573-8F7ED134-0A3E-4E33-9E14-F0323366EB4AQ37481361-3C3B74FA-920F-4CA4-AC0E-0E408E68F533Q37576001-77622085-DE51-457C-AB5D-C7D71C6E0D85Q37697520-3F9691A7-4E0C-4254-8EAA-3F4F551DAFD2Q37706085-79DE58EB-A977-4678-9C66-01E0A961B32AQ37728913-37E74136-5C8F-4762-8D0E-7941F1F7BF0BQ37731978-9342F18D-C3A9-4601-9923-E73C6326D9E3Q37737540-3456C283-334B-4069-8584-055675AC1454Q37822747-4B0BE933-F1B2-476E-B192-A4E447E6BE26
P2860
V gamma 9V delta 2 T cell response to colon carcinoma cells.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
V gamma 9V delta 2 T cell response to colon carcinoma cells.
@ast
V gamma 9V delta 2 T cell response to colon carcinoma cells.
@en
V gamma 9V delta 2 T cell response to colon carcinoma cells.
@nl
type
label
V gamma 9V delta 2 T cell response to colon carcinoma cells.
@ast
V gamma 9V delta 2 T cell response to colon carcinoma cells.
@en
V gamma 9V delta 2 T cell response to colon carcinoma cells.
@nl
prefLabel
V gamma 9V delta 2 T cell response to colon carcinoma cells.
@ast
V gamma 9V delta 2 T cell response to colon carcinoma cells.
@en
V gamma 9V delta 2 T cell response to colon carcinoma cells.
@nl
P2093
P1476
V gamma 9V delta 2 T cell response to colon carcinoma cells.
@en
P2093
Agnès Moreau-Aubry
Elisabeth Diez
Emmanuel Scotet
Francine Jotereau
Jaafar Bennouna
Jean-Francois Mosnier
Marc Bonneville
Murielle Corvaisier
P304
P356
10.4049/JIMMUNOL.175.8.5481
P407
P577
2005-10-01T00:00:00Z